Autophagy

Dr. Sarah Chen
PhD, Molecular Biology
Autophagy (from Greek auto- "self" and phagein "to eat") is a conserved cellular degradation process in which cytoplasmic contents — including damaged proteins, dysfunctional organelles, and aggregated macromolecules — are enclosed within double-membrane vesicles called autophagosomes and delivered to lysosomes for enzymatic breakdown and recycling [1,5].
Definition
Autophagy (from Greek auto- "self" and phagein "to eat") is a conserved cellular degradation process in which cytoplasmic contents — including damaged proteins, dysfunctional organelles, and aggregated macromolecules — are enclosed within double-membrane vesicles called autophagosomes and delivered to lysosomes for enzymatic breakdown and recycling [1][5]. The resulting amino acids, nucleotides, and lipids are released back into the cytoplasm for reuse in biosynthetic and energy-producing pathways [1]. Autophagy is essential for cellular homeostasis, stress adaptation, and quality control — and its decline with age is now recognized as a key driver of tissue aging, including skin aging [2][5].
Types of Autophagy
Three main forms of autophagy have been characterized in mammalian cells [1]:
Macroautophagy
The most extensively studied form, and the one most relevant to skin biology. Macroautophagy involves the formation of a double-membrane isolation membrane (phagophore) that engulfs a portion of cytoplasm, forming an autophagosome. The autophagosome then fuses with a lysosome, and its contents are degraded by lysosomal hydrolases [1][5]. When "autophagy" is used without qualification in the skincare and dermatology literature, it typically refers to macroautophagy [2].
Microautophagy
Direct invagination of the lysosomal membrane to engulf small portions of cytoplasm. Less studied in the skin context [1].
Chaperone-mediated autophagy (CMA)
A selective process in which specific proteins bearing a KFERQ-like targeting motif are recognized by the chaperone Hsc70 and translocated directly across the lysosomal membrane for degradation [1]. CMA is important for the selective removal of damaged proteins and has been implicated in the response to oxidative stress in skin cells [2].
Autophagy in Skin Biology
Fibroblast quality control
Dermal fibroblasts — the primary collagen-producing cells and the main cellular target of PDRN therapy — rely on autophagy to maintain their functional capacity [2][4]. Autophagy removes damaged mitochondria (mitophagy), misfolded proteins, and dysfunctional endoplasmic reticulum segments that would otherwise accumulate and impair fibroblast function [1][2]. A fibroblast with efficient autophagy is a healthier, more productive collagen-synthesizing cell [2].
Keratinocyte differentiation
In the epidermis, autophagy plays a critical role in keratinocyte differentiation — the process by which basal keratinocytes mature, move upward through the epidermal layers, and ultimately form the stratum corneum (the skin's protective outer barrier) [2]. Disrupted autophagy in keratinocytes leads to abnormal differentiation and impaired barrier function [2].
DNA damage response
Autophagy is directly linked to the nucleotide excision repair (NER) pathway, which repairs UV-induced DNA damage in skin cells [6]. Cells with active autophagy are more efficient at recognizing and repairing UV-induced pyrimidine dimers, the primary mutagenic lesions caused by solar radiation [6]. This connection between autophagy and DNA repair is particularly relevant in the context of skin photoaging.
Melanocyte regulation
Autophagy in melanocytes and keratinocytes influences melanin processing and distribution [2]. Disrupted autophagic degradation of melanosomes (melanin-containing organelles) can contribute to pigmentation disorders including melasma and post-inflammatory hyperpigmentation [2].
Autophagy and Skin Aging
Autophagy declines with age across virtually all tissues, and the skin is no exception [2][5]:
Reduced autophagic flux in aged fibroblasts
Aged fibroblasts show decreased expression of key autophagy genes (Atg5, Atg7, Beclin-1) and reduced autophagic flux — the rate at which autophagosomes form and are processed [2][5]. This means damaged proteins and organelles accumulate rather than being recycled, progressively impairing fibroblast function [2].
Accumulation of lipofuscin
One visible consequence of declining autophagy is the accumulation of lipofuscin — an insoluble aggregate of oxidized proteins, lipids, and metals — in aged cells [5]. Lipofuscin cannot be degraded by the proteasome or autophagy once fully crosslinked, and its accumulation is a hallmark of cellular aging that correlates with reduced cellular function [5].
Senescence-autophagy connection
The relationship between autophagy and cellular senescence (the permanent arrest of cell division) is complex and context-dependent [2][5]. In some settings, autophagy suppresses senescence by maintaining cellular quality and removing senescence-inducing damaged components. In others, autophagy may facilitate the transition to senescence by providing the energy and building blocks needed for the senescence-associated secretory phenotype (SASP) [5]. The net effect of declining autophagy with age appears to be an increase in dysfunctional senescent fibroblasts in the dermis [2].
UV-induced autophagy impairment
Chronic UV exposure damages the autophagic machinery itself, creating a vicious cycle: UV generates damaged proteins and DNA that require autophagic clearance, but UV also impairs the autophagy process, allowing damage to accumulate [2][6]. This contributes to the accelerated aging seen in photoexposed skin.
PDRN and Autophagy
The relationship between PDRN and autophagy is indirect but biologically meaningful [3][4]:
Nucleotide supply and cellular energetics
Autophagy requires cellular energy (ATP) and nucleotide substrates for the synthesis of new autophagic membranes and the downstream biosynthetic processes that use recycled components [1][3]. PDRN provides nucleotide building blocks through the salvage pathway and enhances cellular energetics through A2A receptor-mediated cAMP signaling [3][4]. By improving the cell's energy status and nucleotide availability, PDRN may create conditions more favorable for efficient autophagic processing [3].
Anti-inflammatory environment
Chronic inflammation — particularly the elevated levels of TNF-alpha, IL-1 beta, and IL-6 found in aged and photoaged skin — can dysregulate autophagy [2][3]. PDRN's anti-inflammatory action, mediated by A2A receptor activation and cytokine suppression, helps normalize the inflammatory milieu in the dermis, potentially supporting more normal autophagic function in fibroblasts and other dermal cells [3][4].
Fibroblast rejuvenation
By stimulating fibroblast proliferation and activity through A2A receptor signaling, PDRN promotes the expansion of healthier, more active fibroblast populations [3][4]. Actively proliferating cells generally maintain higher autophagic flux than quiescent or senescent cells, suggesting that PDRN-mediated fibroblast activation may indirectly support better autophagy-mediated quality control [2][4].
Clinical Significance
The recognition of autophagy as a key regulator of skin aging has opened new perspectives on anti-aging skincare strategy [2][5]. Approaches that maintain or restore autophagic capacity in dermal fibroblasts — including caloric restriction mimetics, mTOR pathway modulation, and fibroblast-activating biostimulators like PDRN — represent a more fundamental approach to skin aging than treatments that target only the extracellular matrix [2][3]. Supporting the cell's internal quality control system ensures that fibroblasts remain functional and productive for longer, sustaining their ability to synthesize collagen, elastin, and other ECM components throughout the aging process [2][4].
References
- [1]Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728-741. doi:10.1016/j.cell.2011.10.026
- [2]Eckhart L, Tschachler E, Gruber F. Autophagic control of skin aging. Front Cell Dev Biol. 2019;7:143. doi:10.3389/fcell.2019.00143
- [3]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [4]Colangelo MT, Galli C, Giannelli M. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Curr Pharm Des. 2020;26(17):2049-2056.
- [5]Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell. 2011;146(5):682-695. doi:10.1016/j.cell.2011.07.030
- [6]Qiang L, Zhao B, Shah P, Sample A, Yang S, He YY. Autophagy positively regulates DNA damage recognition by nucleotide excision repair. Autophagy. 2016;12(2):357-368. doi:10.1080/15548627.2015.1110667